mypanchang.com
← Panchang

Mundane Transits

6 October 2026 · Saturn, Jupiter, Rahu, Ketu, Mars, Sun

Saturn in Revati

Pada 1 · Navamsha Sagittarius · Logistics Completion, Customs/Border Trade & Safe-Passage Networks
Moderate
Pada 1Pada 2Pada 3Pada 4

Saturn is transiting Revati (pada 1, navamsha Sagittarius, rashi Pisces), from 17 May 2026 to 9 October 2026. This passage comes eased by natural support from the nakshatra's ruling influence, with earlier decisions reopened and reversed and compounded by the instability of a sign-junction crossing. Customs, Border Logistics & Safe-Passage Supply Chains experiences bottlenecks and cost pressure, with aging infrastructure and deferred maintenance becoming harder to ignore. In parallel, border/Customs Regulation & Trade-Facilitation Policy faces tightened rules, slower approvals and stricter enforcement, with compliance costs rising before conditions ease. The same pressure appears in trade Settlement & Cross-Border Payment Networks comes under valuation pressure from tightening conditions, with patience required before structural gains show through. On balance, the overall tone calls for measured attention rather than alarm.

Transit window: 17 May 2026 → 9 Oct 2026

Jupiter in Ashlesha

Pada 3 · Navamsha Aquarius · Cybersecurity, Pharmaceuticals & Covert Intelligence
Low
Pada 1Pada 2Pada 3Pada 4

Jupiter is transiting Ashlesha (pada 3, navamsha Aquarius, rashi Cancer), from 18 August 2026 to 31 October 2026. This passage comes compounded by friction with the nakshatra's own ruling influence and with the placement's own strength reinforcing follow-through. Cyber Intelligence, Encryption & Covert Data Networks is framed with cautious optimism, with expert commentary and institutional voices carrying more weight than speculation. In parallel, pharmaceuticals, Toxicology & Biochemical Industries sees broad-based expansion and capacity growth, with investment favouring scale over speed. The same pressure appears in intelligence Services & Covert Regulatory Enforcement benefits from expansive, principle-guided policy support, with institutions favouring steady growth over disruption. On balance, the overall tone favours steady, low-friction developments.

Transit window: 18 Aug 2026 → 31 Oct 2026

Rahu (madhyama) in Dhanishta

Pada 3 · Navamsha Libra · Social Media, Disinformation, AI Defense, Rare Earths
Moderate
Pada 1Pada 2Pada 3Pada 4

Rahu is transiting Dhanishta (pada 3, navamsha Libra, rashi Aquarius), from 1 August 2026 to 10 April 2027. Social Platforms & Viral Algorithms is amplified by synthetic content, coordinated inauthentic activity and algorithmic distortion, with authenticity increasingly hard to verify. In parallel, government Legal Enforcement & Anonymity draws abrupt, heavy-handed intervention: bans, forced identification and emergency powers invoked faster than due process allows. The same pressure appears in military AI & Rare Earth Metals faces opaque intermediaries, stockpiling and sudden embargo or export-control risk. On balance, the overall tone calls for measured attention rather than alarm.

Transit window: 1 Aug 2026 → 10 Apr 2027

Ketu (madhyama) in Magha

Pada 1 · Navamsha Aries · Heritage Institutions, Ceremonial Authority & Legacy Wealth
Moderate
Pada 1Pada 2Pada 3Pada 4

Ketu is transiting Magha (pada 1, navamsha Aries, rashi Leo), from 28 March 2026 to 5 December 2026. This passage comes at a structurally unstable junction. Ceremonial Authority, Legacy Institutions & Succession Politics sees a sudden withdrawal of support or attention, with oversight gaps opening exactly where enforcement quietly steps back. In parallel, inherited Wealth, Family Trusts & Legacy Capital experiences sudden, poorly explained capital flight, with positions unwound abruptly and little warning given. The same pressure appears in heritage Media, Genealogy & Ancestral Archives loses coherent narrative control, with fragmented, cryptic or under-reported coverage leaving real developments obscured. On balance, the overall tone calls for measured attention rather than alarm.

Transit window: 28 Mar 2026 → 5 Dec 2026

Mars in Pushya

Pada 3 · Navamsha Libra · Healthcare Institutions, Nutrition & Charitable Trusts
Moderate
Pada 1Pada 2Pada 3Pada 4

Mars is transiting Pushya (pada 3, navamsha Libra, rashi Cancer), from 23 September 2026 to 17 October 2026. This passage comes though execution repeatedly falls short of intent. Public Health Institutions & Nourishment Standards faces assertive enforcement action, with authorities moving quickly and sometimes aggressively to assert control. In parallel, nutrition, Dairy & Food-Fortification Industries sees intense operational activity and accelerated execution, though strain and accidents grow more likely under the pace. The same pressure appears in healthcare & Institutional Trust Financing experiences sharp, high-energy moves, with aggressive positioning cutting both ways. On balance, the overall tone calls for measured attention rather than alarm.

Transit window: 23 Sep 2026 → 17 Oct 2026

Sun in Hasta

Pada 3 · Navamsha Gemini · Skilled Manufacturing, Artisan Trades & Precision Industry
Low
Pada 1Pada 2Pada 3Pada 4

Sun is transiting Hasta (pada 3, navamsha Gemini, rashi Virgo), from 27 September 2026 to 10 October 2026. This passage comes eased by natural support from the nakshatra's ruling influence. Precision Manufacturing & Artisan/Craft Industries experiences confident, top-down direction, with resources concentrated toward flagship priorities. In parallel, small-Manufacturer Credit & Skilled-Trade Markets draws confidence-driven capital, with valuation increasingly tied to visible leadership performance. The same pressure appears in vocational Training Media & Skill-Certification Platforms moves into the spotlight, drawing sustained institutional attention and higher public visibility than usual. On balance, the overall tone favours steady, low-friction developments.

Transit window: 27 Sep 2026 → 10 Oct 2026
Traditional mundane astrological interpretation, offered for study and reflection. Not financial, investment, legal, medical, or professional advice. No outcome is predicted or guaranteed. Read the full disclaimer.